Patents by Inventor Robin Ernst

Robin Ernst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monospecific and multispecific anti-TMEFF2 antibodies and their uses
    Patent number: 11866499
    Abstract: The disclosure provided herein relates to monospecific and multispecific anti-TMEFF2 antibodies, and methods of producing and using the described antibodies.
    Type: Grant
    Filed: May 21, 2019
    Date of Patent: January 9, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Philip Cooper, Robin Ernst, Rajkumar Ganesan, Colleen Kane, Michael Russell, Sanjaya Singh, Sathyadevi Venkataramani, Sheng-Jiun Wu
  • MONOSPECIFIC AND MULTISPECIFC ANTI-TMEFF2 ANTIBODIES AND THEIR USES
    Publication number: 20190359711
    Abstract: The disclosure provided herein relates to monospecific and multispecific anti-TMEFF2 antibodies, and methods of producing and using the described antibodies.
    Type: Application
    Filed: May 21, 2019
    Publication date: November 28, 2019
    Applicant: Janssen Biotech, Inc.
    Inventors: Philip Cooper, Robin Ernst, Rajkumar Ganesan, Colleen Kane, Michael Russell, Sanjaya Singh, Sathyadevi Venkataramani, Sheng-Jiun Wu
  • Antibodies Specifically Binding HLA-DR and Their Uses
    Publication number: 20180355043
    Abstract: The present invention relates antibodies or antigen-binding fragments thereof specifically binding HLA-DR, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.
    Type: Application
    Filed: December 16, 2016
    Publication date: December 13, 2018
    Inventors: Christian Martinez, Qiang Chen, Melissa Swiecki, Robert Kuhn, Hong Zhou, Karen Duffy, Stephane Becart, Chichi Huang, Xiefan Lin-Schmidt, Sheng-Jiun Wu, Jeffrey Luo, Galina Obmolova, Robin Ernst
  • Antigen-Binding Proteins Targeting S. Aureus Orf0657n
    Publication number: 20110091480
    Abstract: The present invention features antigen binding protein that bind an ORF0657n target region (SEQ ID NO: 1). ORF0657n is an S. aureus protein. ORF0657n target regions are provided by the mAb 1G3.BD4, mAb 2H2.BE11, mAb 13C7.BC1, and mAb 13G11.BF3 binding sites. In a lethal model challenge, mAb 2H2.BE11 and mAb 13C7.BC1 provided for increased survival against S. aureus infection. There was also protection demonstrated in an ex vivo model with either the IgG1 or the IgG2b form of mAb 2H2; and in a passive immunization murine indwelling catheter model using mAb 2H2.BE11.
    Type: Application
    Filed: January 23, 2007
    Publication date: April 21, 2011
    Inventors: Martha J. Brown, Annaliesa S. Anderson, Leslie D. Cope, Kathrin Ute Jansen, Tessie McNeely, Barrett R. Harvey, Eberhard Durr, Robin Ernst